BCM
IRON icon

Bayesian Capital Management’s Disc Medicine IRON Stock Holding History

Bayesian Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,497
Closed -$285K – 780
2024
Q4 		$285K Buy
+4,497
New +$260K 0.03% 490

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bayesian Capital Management's IRON Position: Q1 2025 in Review

Bayesian Capital Management sold out of Disc Medicine (IRON) in Q1 2025, closing a stake of 4,497 shares — an estimated $285K sold.

Bayesian Capital Management first reported a position in IRON in Q4 2024 and held it in 1 quarter. The position peaked at $285K in Q4 2024. 157 funds tracked by Wall St. Rank hold IRON as of Q1 2025.

  • Bayesian Capital Management reported no remaining Disc Medicine position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 4,497 Disc Medicine shares in Q1 2025, an estimated $285K.
  • Bayesian Capital Management first reported a position in Disc Medicine in Q4 2024 and held it in 1 quarter.
  • Bayesian Capital Management's Disc Medicine position peaked at $285K in Q4 2024.
  • 157 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.